Barbara, Here is something else that looks positive. I'm susprised that they didn't answer your mail. Try again
Ken Moss
Subj: Bio Fluorescent Technologies announces agreement with Immune Network Research Lt
Date: 97-02-12 11:52:22 EST
From: staff@quote.com
To: quotecom-users@quote.com
News Alert from BusinessWire via Quote.com
Topic: Bio Florescent Technlgys (New)
Quote.com News Item #2059310
Headline: Bio Fluorescent Technologies announces agreement with Immune Network
Research Ltd.
======================================================================
SCOTTSDALE, Ariz.--(BW HealthWire)--Feb. 12, 1997--Bio
Fluorescent Technologies Inc. (BFTI) (OTC BB:BFTK) Wednesday
announced that it has reached an agreement in principle to acquire
all of the assets of Immune Network Research Ltd. ("INR"), of
Vancouver, British Columbia, Canada, for approximately 9 million
BFTI common shares.
INR is engaged in the research and development of immunological
products for the diagnosis, prevention and treatment of AIDS and
other human immune system disorders.
Over the past four years, INR has assembled a highly qualified
scientific team experienced in advanced research in the treatment of
human immune system disorders.
Shareholders of both companies should benefit from BFTI's access
to the large capital markets for biotechnology companies in the
United States and the participation by both companies in the
continuing development of INR's assets.
The transaction is subject to INR shareholder approval,
regulatory approval, satisfactory results from due diligence efforts
by both companies and finalization of the precise structure of the
transaction.
CONTACT: Bio Fluorescent Technologies Inc., Scottsdale
George, 800/870-1233
KEYWORD: ARIZONA
IN |
